FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003474906> ?p ?o ?g. }

• W2003474906 endingPage "610" @default.
• W2003474906 startingPage "603" @default.
• W2003474906 abstract "Malignant mesothelioma (MM) is a locally aggressive tumor that originates from the mesothelial cells of the pleural and sometimes peritoneal surface. Conventional treatments for MM, consisting of chemotherapy or surgery give little survival benefit to patients, who generally die within 1 year of diagnosis. Hence, there is an urgent need for the development of alternative therapies. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for MM. The closely related molecule, VEGF-C, is also implicated in malignant mesothelioma growth. VEGF-C and its cognate receptor VEGFR-3 are co-expressed in mesothelioma cell lines. A functional VEGF-C autocrine growth loop was demonstrated in mesothelioma cells by targeting VEGF-C expression and binding to VEGFR-3. The ability of novel agents that reduce the levels of VEGF and VEGF-C to inhibit mesothelioma cell growth in vitro was assessed. Antisense oligonucleotide (ODN) complementary to VEGF that inhibited VEGF and VEGF-C expression simultaneously specifically inhibited mesothelioma cell growth. Similarly, antibodies to VEGF receptor (VEGFR-2) and VEGF-C receptor (VEGFR-3) were synergistic in inhibiting mesothelioma cell growth. In addition, a diphtheria toxin-VEGF fusion protein (DT-VEGF), which is toxic to cells that express VEGF receptors was very effective in inhibiting mesothelioma cell growth in vitro. These results indicate that targeting VEGF and VEGF-C simultaneously may be an effective therapeutic approach for malignant mesothelioma." @default.
• W2003474906 created "2016-06-24" @default.
• W2003474906 creator A5005395952 @default.
• W2003474906 creator A5012965276 @default.
• W2003474906 creator A5044733560 @default.
• W2003474906 creator A5047679990 @default.
• W2003474906 creator A5070664714 @default.
• W2003474906 creator A5084721547 @default.
• W2003474906 creator A5091485724 @default.
• W2003474906 date "2003-02-19" @default.
• W2003474906 modified "2023-10-11" @default.
• W2003474906 title "Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops" @default.
• W2003474906 cites W1570971207 @default.
• W2003474906 cites W1586806649 @default.
• W2003474906 cites W1885629825 @default.
• W2003474906 cites W1964714244 @default.
• W2003474906 cites W1967007810 @default.
• W2003474906 cites W1977062776 @default.
• W2003474906 cites W1977285769 @default.
• W2003474906 cites W1983763042 @default.
• W2003474906 cites W1986109557 @default.
• W2003474906 cites W1992212640 @default.
• W2003474906 cites W1993220471 @default.
• W2003474906 cites W1995637683 @default.
• W2003474906 cites W2008018400 @default.
• W2003474906 cites W2009427112 @default.
• W2003474906 cites W2014943535 @default.
• W2003474906 cites W2023052504 @default.
• W2003474906 cites W2036260794 @default.
• W2003474906 cites W2040972148 @default.
• W2003474906 cites W2044689705 @default.
• W2003474906 cites W2047409416 @default.
• W2003474906 cites W2062906481 @default.
• W2003474906 cites W2074770401 @default.
• W2003474906 cites W2079368895 @default.
• W2003474906 cites W2081508876 @default.
• W2003474906 cites W2084768201 @default.
• W2003474906 cites W2086069923 @default.
• W2003474906 cites W2098444281 @default.
• W2003474906 cites W2121220148 @default.
• W2003474906 cites W2135638162 @default.
• W2003474906 cites W2146021659 @default.
• W2003474906 cites W2172264076 @default.
• W2003474906 cites W2205531104 @default.
• W2003474906 doi "https://doi.org/10.1002/ijc.10996" @default.
• W2003474906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12594815" @default.
• W2003474906 hasPublicationYear "2003" @default.
• W2003474906 type Work @default.
• W2003474906 sameAs 2003474906 @default.
• W2003474906 citedByCount "137" @default.
• W2003474906 countsByYear W20034749062012 @default.
• W2003474906 countsByYear W20034749062013 @default.
• W2003474906 countsByYear W20034749062014 @default.
• W2003474906 countsByYear W20034749062015 @default.
• W2003474906 countsByYear W20034749062016 @default.
• W2003474906 countsByYear W20034749062017 @default.
• W2003474906 countsByYear W20034749062018 @default.
• W2003474906 countsByYear W20034749062019 @default.
• W2003474906 countsByYear W20034749062020 @default.
• W2003474906 countsByYear W20034749062021 @default.
• W2003474906 countsByYear W20034749062022 @default.
• W2003474906 countsByYear W20034749062023 @default.
• W2003474906 crossrefType "journal-article" @default.
• W2003474906 hasAuthorship W2003474906A5005395952 @default.
• W2003474906 hasAuthorship W2003474906A5012965276 @default.
• W2003474906 hasAuthorship W2003474906A5044733560 @default.
• W2003474906 hasAuthorship W2003474906A5047679990 @default.
• W2003474906 hasAuthorship W2003474906A5070664714 @default.
• W2003474906 hasAuthorship W2003474906A5084721547 @default.
• W2003474906 hasAuthorship W2003474906A5091485724 @default.
• W2003474906 hasBestOaLocation W20034749061 @default.
• W2003474906 hasConcept C103041312 @default.
• W2003474906 hasConcept C126322002 @default.
• W2003474906 hasConcept C128240485 @default.
• W2003474906 hasConcept C142724271 @default.
• W2003474906 hasConcept C146285616 @default.
• W2003474906 hasConcept C167734588 @default.
• W2003474906 hasConcept C170493617 @default.
• W2003474906 hasConcept C2777025900 @default.
• W2003474906 hasConcept C2777407522 @default.
• W2003474906 hasConcept C2780394083 @default.
• W2003474906 hasConcept C502942594 @default.
• W2003474906 hasConcept C71924100 @default.
• W2003474906 hasConcept C86803240 @default.
• W2003474906 hasConceptScore W2003474906C103041312 @default.
• W2003474906 hasConceptScore W2003474906C126322002 @default.
• W2003474906 hasConceptScore W2003474906C128240485 @default.
• W2003474906 hasConceptScore W2003474906C142724271 @default.
• W2003474906 hasConceptScore W2003474906C146285616 @default.
• W2003474906 hasConceptScore W2003474906C167734588 @default.
• W2003474906 hasConceptScore W2003474906C170493617 @default.
• W2003474906 hasConceptScore W2003474906C2777025900 @default.
• W2003474906 hasConceptScore W2003474906C2777407522 @default.
• W2003474906 hasConceptScore W2003474906C2780394083 @default.
• W2003474906 hasConceptScore W2003474906C502942594 @default.
• W2003474906 hasConceptScore W2003474906C71924100 @default.
• W2003474906 hasConceptScore W2003474906C86803240 @default.
• W2003474906 hasIssue "5" @default.

• next